VIRGINIA RETIREMENT SYSTEMS ET Al Invests $4.48 Million in Humana Inc. $HUM

VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of Humana Inc. (NYSE:HUM) in the second quarter, HoldingsChannel.com reports. The institutional investor purchased 11,284 shares of the insurance provider’s stock, valued at approximately $4,482,000.

Other hedge funds also recently added to or reduced their stakes in the company. Wilkerson Advisory Group LLC raised its position in Humana by 24.6% in the 2nd quarter. Wilkerson Advisory Group LLC now owns 167 shares of the insurance provider’s stock worth $66,000 after purchasing an additional 33 shares during the period. Bogart Wealth LLC boosted its position in shares of Humana by 192.0% during the second quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock valued at $29,000 after buying an additional 48 shares during the period. Fiduciary Alliance LLC grew its stake in shares of Humana by 0.9% during the first quarter. Fiduciary Alliance LLC now owns 5,628 shares of the insurance provider’s stock valued at $976,000 after buying an additional 49 shares during the last quarter. Johnson Financial Group Inc. bought a new position in shares of Humana during the second quarter valued at approximately $26,000. Finally, CoreCap Advisors LLC raised its holdings in shares of Humana by 74.7% in the second quarter. CoreCap Advisors LLC now owns 159 shares of the insurance provider’s stock worth $63,000 after buying an additional 68 shares during the period. 92.38% of the stock is currently owned by institutional investors.

Humana Stock Performance

Shares of HUM stock opened at $401.06 on Thursday. The firm has a market cap of $48.16 billion, a price-to-earnings ratio of 37.94, a PEG ratio of 2.64 and a beta of 0.74. The company’s 50 day moving average is $388.61 and its 200 day moving average is $301.31. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $428.88.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. The company had revenue of $40.89 billion during the quarter, compared to analyst estimates of $40.58 billion. Humana had a return on equity of 11.20% and a net margin of 0.88%.Humana’s revenue was up 26.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $6.27 earnings per share. On average, sell-side analysts anticipate that Humana Inc. will post 9 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 27th. Investors of record on Friday, October 30th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Friday, October 30th. Humana’s dividend payout ratio is 33.49%.

Analyst Upgrades and Downgrades

HUM has been the subject of a number of recent analyst reports. Bank of America upgraded Humana from a “neutral” rating to a “buy” rating and set a $500.00 price objective for the company in a report on Wednesday, July 29th. Piper Sandler upgraded Humana from a “hold” rating to an “overweight” rating and set a $463.00 target price on the stock in a research note on Thursday, July 30th. Evercore upgraded Humana from an “in-line” rating to an “outperform” rating and set a $480.00 target price for the company in a research report on Wednesday, July 29th. JPMorgan Chase & Co. boosted their target price on shares of Humana from $316.00 to $393.00 and gave the company a “neutral” rating in a research note on Monday, August 10th. Finally, Lake Street Capital started coverage on shares of Humana in a research note on Thursday, July 30th. They issued a “buy” rating on the stock. Fourteen analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $403.91.

Humana Profile

Humana Inc (NYSE:HUM) is a U.S.-based health insurance and health care services company focused primarily on government-sponsored programs. Its offerings include Medicare Advantage plans, Medicare prescription drug plans, Medicaid coverage and specialty insurance products, serving individuals, employers and government organizations.

Through its CenterWell business, Humana also provides senior-focused primary care, pharmacy services and home health care. These operations are designed to support coordinated care for older adults and other members with ongoing health care needs.

Humana was founded in 1961 as a nursing-home company and later expanded into hospital ownership before shifting its focus toward health insurance.